Switching from tenofovir disoproxil fumarate to bictegravir/emtricitabine/ tenofovir alafenamide or non-tenofovir alafenamide regimens: a real-world study of safety and efficacy in Chinese people living with HIV

Fada Wang, Liyuan Zheng, Xiaojing Song, Leidan Zhang, Ling Chen, Yanling Li, Yang Han, Wei Yu, Wei Cao, Taisheng Li

Open source

DOI
10.1080/14787210.2026.2718183
Published
2026-08-18
Container
Expert Review of Anti-infective Therapy
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14787210.2026.2718183,
  title = {Switching from tenofovir disoproxil fumarate to bictegravir/emtricitabine/ tenofovir alafenamide or non-tenofovir alafenamide regimens: a real-world study of safety and efficacy in Chinese people living with HIV},
  author = {Fada Wang and Liyuan Zheng and Xiaojing Song and Leidan Zhang and Ling Chen and Yanling Li and Yang Han and Wei Yu and Wei Cao and Taisheng Li},
  year = {2026},
  journal = {Expert Review of Anti-infective Therapy},
  doi = {10.1080/14787210.2026.2718183},
  url = {https://doi.org/10.1080/14787210.2026.2718183}
}

RIS

TY  - JOUR
TI  - Switching from tenofovir disoproxil fumarate to bictegravir/emtricitabine/ tenofovir alafenamide or non-tenofovir alafenamide regimens: a real-world study of safety and efficacy in Chinese people living with HIV
AU  - Fada Wang
AU  - Liyuan Zheng
AU  - Xiaojing Song
AU  - Leidan Zhang
AU  - Ling Chen
AU  - Yanling Li
AU  - Yang Han
AU  - Wei Yu
AU  - Wei Cao
AU  - Taisheng Li
PY  - 2026
JO  - Expert Review of Anti-infective Therapy
DO  - 10.1080/14787210.2026.2718183
UR  - https://doi.org/10.1080/14787210.2026.2718183
ER  - 

APA

Wang, F., Zheng, L., Song, X., Zhang, L., Chen, L., Li, Y., Han, Y., Yu, W., Cao, W., & Li, T. (2026). Switching from tenofovir disoproxil fumarate to bictegravir/emtricitabine/ tenofovir alafenamide or non-tenofovir alafenamide regimens: a real-world study of safety and efficacy in Chinese people living with HIV. Expert Review of Anti-infective Therapy. https://doi.org/10.1080/14787210.2026.2718183

Source records